How much does Kerendia (Finerenone Tablets) Cost& price without insurance in China?
Kerendia® is the commercial brand name of Finerenone Tablets, an orally active nonsteroidal mineralocorticoid receptor antagonist developed by Bayer. It selectively blocks mineralocorticoid receptor to reduce renal inflammation and fibrosis, slowing renal function decline.
Main Indications
Treatment of adult patients with chronic kidney disease associated with type 2 diabetes mellitus (eGFR 25~75 mL/min/1.73m² with albuminuria), to reduce the risk of sustained eGFR decline and end-stage renal disease.
Common Side Effects
Common mild adverse reactions: Hyperkalemia, hypotension, nausea and fatigue.
Laboratory abnormalities: Elevated serum potassium and transient mild creatinine rise.
Severe but manageable risks: Severe hyperkalemia leading to arrhythmia and hypersensitivity reactions.
Approval Status in China
Kerendia® (Finerenone Tablets,10mg, domestic Chinese brand name: Keshinda) was officially approved for marketing in China in 2022. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Kerendia (Finerenone Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
